Fernández-Martínez, J.L.; Álvarez-Machancoses, Ó.; deAndrés-Galiana, E.J.; Bea, G.; Kloczkowski, A.
Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning. Int. J. Mol. Sci. 2020, 21, 3594.
https://doi.org/10.3390/ijms21103594
AMA Style
Fernández-Martínez JL, Álvarez-Machancoses Ó, deAndrés-Galiana EJ, Bea G, Kloczkowski A.
Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning. International Journal of Molecular Sciences. 2020; 21(10):3594.
https://doi.org/10.3390/ijms21103594
Chicago/Turabian Style
Fernández-Martínez, Juan Luis, Óscar Álvarez-Machancoses, Enrique J. deAndrés-Galiana, Guillermina Bea, and Andrzej Kloczkowski.
2020. "Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning" International Journal of Molecular Sciences 21, no. 10: 3594.
https://doi.org/10.3390/ijms21103594
APA Style
Fernández-Martínez, J. L., Álvarez-Machancoses, Ó., deAndrés-Galiana, E. J., Bea, G., & Kloczkowski, A.
(2020). Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning. International Journal of Molecular Sciences, 21(10), 3594.
https://doi.org/10.3390/ijms21103594